Advertisement

Vulvar Pruritus

  • Nicholas Lawrance
  • Jennifer Yell
Chapter

Abstract

Vulvar pruritus is a common symptom, which, if protracted, causes significant distress. Rapid resolution hinges on an accurate diagnosis. This chapter will outline a pragmatic clinical approach to a patient with pruritus, leading to an accurate assessment, thereby allowing effective, adequate treatment. It will briefly cover the pathophysiology of pruritus and the main differential diagnoses, with clear clinical pointers to diagnosis, ending with general along with specific treatment options.

References

  1. 1.
    Harlow BL, Wise LA, Stewart EG. Prevalence and predictors of chronic lower genital tract discomfort. Am J Obstet Gynecol. 2001;185:545–50.  https://doi.org/10.1067/mob.2001.116748.CrossRefPubMedGoogle Scholar
  2. 2.
    Doxanakis A, Fairley CK, Bradshaw C. Vulval itch: all that itches is not thrush. Med Today. 2004;5:54–64.Google Scholar
  3. 3.
    Bohl TG. Overview of vulvar pruritus through the life cycle. Clin Obstet Gynecol. 2005;48:786–807.CrossRefGoogle Scholar
  4. 4.
    Twycross R, Greaves MW, Handwerker H, et al. Itch: scratching more than the surface. QJM. 2003;96:7–26.CrossRefGoogle Scholar
  5. 5.
    Ebata T, Iwasaki S, Kamide R, Niimura M. Use of a wrist activity monitor for the measurement of nocturnal scratching in patients with atopic dermatitis. Br J Dermatol. 2001;144:305–9.CrossRefGoogle Scholar
  6. 6.
    Hägermark O, Wahlgren CF. Some methods for evaluating clinical itch and their application for studying pathophysiological mechanisms. J Dermatol Sci. 1992;4:55–62.CrossRefGoogle Scholar
  7. 7.
    Molenaar HA, Oosting J, Jones EA. Improved device for measuring scratching activity in patients with pruritus. Med Biol Eng Comput. 1998;36:220–4.CrossRefGoogle Scholar
  8. 8.
    Akiyama T, Carstens E. Neural processing of itch. Neuroscience. 2013;250:697–714.  https://doi.org/10.1016/j.neuroscience.2013.07.035.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Krause L, Shuster S. Mechanism of action of antipruritic drugs. Br Med J. 1983;287:1199–200.CrossRefGoogle Scholar
  10. 10.
    Lynn B. Capsaicin: actions on C fibre afferents that may be involved in itch. Skin Pharmacol. 1992;5:9–13.CrossRefGoogle Scholar
  11. 11.
    Wahlgren CF, Scheynius A, Hägermark O. Antipruritic effect of oral cyclosporin A in atopic dermatitis. Acta Derm Venereol. 1990;70:323–9.PubMedGoogle Scholar
  12. 12.
    Yosipovitch G, Sugeng MW, Chan YH, et al. The effect of topically applied aspirin on localized circumscribed neurodermatitis. J Am Acad Dermatol. 2001;45:910–3.  https://doi.org/10.1067/mjd.2001.117399.CrossRefPubMedGoogle Scholar
  13. 13.
    Colbert S, O’Hanlon DM, Galvin S, et al. The effect of rectal diclofenac on pruritus in patients receiving intrathecal morphine. Anaesthesia. 1999;54:948–52.CrossRefGoogle Scholar
  14. 14.
    Fischer GO. The commonest causes of symptomatic vulvar disease: a dermatologist’s perspective. Australas J Dermatol. 1996;37:12–8.CrossRefGoogle Scholar
  15. 15.
    Stewart K. Vulvar dermatoses: a practical approach to evaluation and management. JCOM. 2012;19:205–20.Google Scholar
  16. 16.
    Archer CB. Skin and systemic diseases. In: Warell D, Cox T, Firth J, editors. Oxford textbook medicine. 5th ed. Oxford: Oxford University Press; 2010.Google Scholar
  17. 17.
    Weisshaar E, Apfelbacher C, Jäger G, et al. Pruritus as a leading symptom: clinical characteristics and quality of life in German and Ugandan patients. Br J Dermatol. 2006;155:957–64.  https://doi.org/10.1111/j.1365-2133.2006.07430.x.CrossRefPubMedGoogle Scholar
  18. 18.
    Thaipisuttikul Y. Pruritic skin diseases in the elderly. J Dermatol. 1998;25:153–7.CrossRefGoogle Scholar
  19. 19.
    ACOG Practice Bulletin No. 93: diagnosis and management of vulvar skin disorders. Obstet Gynecol. 2008;111:1243–53.  https://doi.org/10.1097/AOG.0b013e31817578ba.
  20. 20.
    Hara M, Kikuchi K. Senile xerosis, functional morphological and biochemical studies. J Geriatr Dermatol. 1993;1:111–20.Google Scholar
  21. 21.
    Nusbaum NJ. Aging and sensory senescence. South Med J. 1999;92:267–75.CrossRefGoogle Scholar
  22. 22.
    Ward JR, Bernhard JD. Willan’s itch and other causes of pruritus in the elderly. Int J Dermatol. 2005;44:267–73.  https://doi.org/10.1111/j.1365-4632.2004.02553.x.CrossRefPubMedGoogle Scholar
  23. 23.
    Ghadially R, Halkier-Sorensen L, Elias PM. Effects of petrolatum on stratum corneum structure and function. J Am Acad Dermatol. 1992;26:387–96.CrossRefGoogle Scholar
  24. 24.
    Biondi M, Arcangeli T, Petrucci RM. Paroxetine in a case of psychogenic pruritus and neurotic excoriations. Psychother Psychosom. 2000;69:165–6.CrossRefGoogle Scholar
  25. 25.
    Tzingounis VA, Aksu MF, Greenblatt RB. Estriol in the management of the menopause. JAMA. 1978;239:1638–41.CrossRefGoogle Scholar
  26. 26.
    NICE. Pruritus vulvae—NICE CKS. 2016. http://cks.nice.org.uk/pruritus-vulvae. Accessed 27 Oct 2016.
  27. 27.
    Epstein E, Pinski JB. A blind study. Arch Dermatol. 1964;89:548–9.CrossRefGoogle Scholar
  28. 28.
    Tennyson H, Levine N. Neurotropic and psychotropic drugs in dermatology. Dermatol Clin. 2001;19:179–97.CrossRefGoogle Scholar
  29. 29.
    Ekblom A, Fjellner B, Hansson P. The influence of mechanical vibratory stimulation and transcutaneous electrical nerve stimulation on experimental pruritus induced by histamine. Acta Physiol Scand. 1984;122:361–7.  https://doi.org/10.1111/j.1748-1716.1984.tb07520.x.CrossRefPubMedGoogle Scholar
  30. 30.
    Lundeberg T, Bondesson L, Thomas M. Effect of acupuncture on experimentally induced itch. Br J Dermatol. 1987;117:771–7.CrossRefGoogle Scholar
  31. 31.
    Taddese A, Nah SY, McCleskey EW. Selective opioid inhibition of small nociceptive neurons. Science. 1995;270:1366–9.CrossRefGoogle Scholar
  32. 32.
    Zylicz Z, Krajnik M, van Sorge AA, Costantini M. Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial. J Pain Symptom Manag. 2003;26:1105–12.CrossRefGoogle Scholar
  33. 33.
    Hundley JL, Yosipovitch G. Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study. J Am Acad Dermatol. 2004;50:889–91.  https://doi.org/10.1016/j.jaad.2004.01.045.CrossRefPubMedGoogle Scholar
  34. 34.
    Demierre M-F, Taverna J. Mirtazapine and gabapentin for reducing pruritus in cutaneous T-cell lymphoma. J Am Acad Dermatol. 2006;55:543–4.  https://doi.org/10.1016/j.jaad.2006.04.025.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Yesudian PD, Wilson NJE. Efficacy of gabapentin in the management of pruritus of unknown origin. Arch Dermatol. 2005;141:1507–9.  https://doi.org/10.1001/archderm.141.12.1507.CrossRefPubMedGoogle Scholar
  36. 36.
    Rivard J, Lim HW. Ultraviolet phototherapy for pruritus. Dermatol Ther. 2005;18:344–54.  https://doi.org/10.1111/j.1529-8019.2005.00032.x.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  • Nicholas Lawrance
    • 1
  • Jennifer Yell
    • 1
  1. 1.British Society for the Study of Vulval DiseaseManchesterUK

Personalised recommendations